- RecruitingPHASE3
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
This study looks at new treatments for a type of blood cancer called Acute Myeloid Leukemia (AML) in people who are newly diagnosed. It's comparing a new drug, bleximenib, with existing treatments (Venetoclax and Azacitidine) and a dummy drug (placebo) to see how well they work.
For: Leukemia, Myeloid, AcuteUnited States · Australia · Austria - RecruitingPHASE1, PHASE2
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
This study is looking at a new medicine called bleximenib for people with acute leukaemia that has come back or hasn't responded to other treatments. It aims to find the right dose and see how safe and effective it is.
For: Acute LeukemiaUnited States · Australia · Belgium - Active not recruitingPHASE1
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
This study is testing a new drug called Bleximenib alongside standard treatments for acute myeloid leukaemia (AML). It aims to find the safest and most effective dose of Bleximenib when given with other AML medicines, and to understand its side effects.
For: Leukemia, Myeloid, AcuteUnited States · Australia · Canada - RecruitingPHASE1
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
This study is looking at a new drug called bleximenib in people with a type of blood cancer called acute leukaemia. Researchers want to understand how the body handles this drug.
For: Acute Lymphoblastic Leukemia · Acute Leukemias · Acute Myeloid LeukemiaUnited Kingdom